Literature DB >> 28381313

Influence of Genetic Background on Hematologic and Histopathologic Alterations during Acute Granulocytic Anaplasmosis in 129/SvEv and C57BL/6J Mice Lacking Type I and Type II Interferon Signaling.

Jennifer L Johns1, Marielle L Discipulo2, Amanda L Koehne3, Kaitlin A Moorhead2, Claude M Nagamine2.   

Abstract

The role of host type I IFN signaling and its interaction with other immune pathways during bacterial infections is incompletely understood. Type II IFN signaling plays a key role during numerous bacterial infections including granulocytic anaplasmosis (GA) caused by Anaplasma phagocytophilum infection. The function of combined type I and type II IFN signaling and their potential synergism during GA and similar tick-borne diseases is a topic of current research investigation. The goal of this study was to evaluate 2 mouse models of absent type I/type II IFN signaling in experimental A. phagocytophilum infection to determine the effects of background strain. Mice lacking both type I and type II IFN receptor signaling (IFNAR-/-/IFNGR-/-) on either the 129/SvEv or C57BL/6J genetic background were evaluated at days 0, 6, 8, and 12 of infection. Pathogen burden in multiple organs was largely similar between strains of infected mice, with few significant differences. Background strain influenced the immune response to infection. Mice of the 129/SvEv strain developed more severe hematologic abnormalities, particularly more severe leukocytosis with marked neutrophilia and lymphocytosis, throughout acute infection. Histopathologic changes occurred in infected mice of both strains and varied in severity by organ. 129/SvEv mice developed more severe pathologic changes in spleen and bone marrow, whereas C57BL/6J mice developed more severe renal pathology. This work highlights the importance of mouse background strain in dictating pathophysiologic response to infection and informs future work regarding the loss of type I and type II IFN signaling on the immune response during GA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28381313      PMCID: PMC5402732     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  55 in total

Review 1.  Tolerance of infections.

Authors:  Janelle S Ayres; David S Schneider
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Death of a horse infected experimentally with Anaplasma phagocytophilum.

Authors:  P Franzén; A-L Berg; A Aspan; A Gunnarsson; J Pringle
Journal:  Vet Rec       Date:  2007-01-27       Impact factor: 2.695

4.  Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation.

Authors:  E Hodzic; S Feng; D Fish; C M Leutenegger; K J Freet; S W Barthold
Journal:  J Infect Dis       Date:  2001-05-17       Impact factor: 5.226

5.  Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections.

Authors:  H Lepidi; J E Bunnell; M E Martin; J E Madigan; S Stuen; J S Dumler
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

Review 6.  The biological basis of severe outcomes in Anaplasma phagocytophilum infection.

Authors:  J Stephen Dumler
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-19

7.  ASC/PYCARD and caspase-1 regulate the IL-18/IFN-gamma axis during Anaplasma phagocytophilum infection.

Authors:  Joao H F Pedra; Fayyaz S Sutterwala; Bindu Sukumaran; Yasunori Ogura; Feng Qian; Ruth R Montgomery; Richard A Flavell; Erol Fikrig
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

8.  Equine ehrlichiosis in northern California: 49 cases (1968-1981).

Authors:  J E Madigan; D Gribble
Journal:  J Am Vet Med Assoc       Date:  1987-02-15       Impact factor: 1.936

9.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

10.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more
  3 in total

1.  Protective effect of Sophora pachycarpa seed extract on carbon tetrachloride-induced toxicity in rats.

Authors:  Hamed Aramjoo; Pouria Mohammadparast-Tabas; Tahereh Farkhondeh; Mahmoud Zardast; Marzieh Makhdoumi; Saeed Samarghandian; Zahra Kiani
Journal:  BMC Complement Med Ther       Date:  2022-03-17

2.  Differential Susceptibility of Male Versus Female Laboratory Mice to Anaplasma phagocytophilum Infection.

Authors:  Waheeda A Naimi; Ryan S Green; Chelsea L Cockburn; Jason A Carlyon
Journal:  Trop Med Infect Dis       Date:  2018-07-23

Review 3.  The Impact of Tick-Borne Diseases on the Bone.

Authors:  Imran Farooq; Tara J Moriarty
Journal:  Microorganisms       Date:  2021-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.